BMT CTN Protocol 0702

A Trial of Single Autologous Transplant with or without Consolidation Therapy versus Tandem Autologous Transplant with Lenalidomide Maintenance for Patients with Multiple Myeloma

Below are protocol-related documents, which may be periodically updated.

            Protocol Co-Chair: Amrita Krishnan, MD (626-256-4673) askrishnan@coh.org

            Protocol Co-Chair: George Somlo, MD (626-359-8111) gsomlo@coh.org

            Protocol Co-Chair: Ed Stadtmauer, MD (215-662-7910) stadtmau@mail.med.upenn.edu

            Protocol Officer: Marcelo Pasquini, MD (414-805-0700) mpasquin@mcw.edu

            Protocol Coordinator: Courtney Nelson (301-251-1161) cnelson@emmes.com

            Medical Monitor: Shannon Smiley, MD slsmiley@anthc.org

 

           

This study reached its target accrual on November 15, 2013 and is now closed to new patient enrollment.